141 results
8-K
EX-99.1
BAX
Baxter International Inc.
2 May 24
Baxter Reports First-quarter 2024 Results
7:17am
, consideration and benefits; failure to accurately forecast or achieve the company’s short- and long-term financial performance and goals (including with respect
8-K
EX-99.1
vjoponvwfnes b5urd9p
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
8-K
EX-99.1
e7day74
2 Nov 23
Baxter Reports Third-quarter 2023 Results
7:18am
8-K
EX-99.1
m21eu4cg
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
EX-99.1
t4zjtv5t7cpm4mk o2he
6 Jul 23
Regulation FD Disclosure
8:30am
8-K
EX-99.1
ir2ke8lyufm6gtzke7i3
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-99.1
h94eew8vlgnl7 mc4u6
27 Apr 23
Baxter Reports First-quarter 2023 Results
7:18am
8-K
EX-99.1
85didjs7 77bmk2c31
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-99.1
xrv2a6bklxt4vyhqsaa
28 Jul 22
Baxter Reports Second-quarter 2022 Results
7:19am
424B3
avoikvk266y
12 May 22
Prospectus supplement
8:58am